Continuous glucose monitors (CGMs) are wearable technologies that track blood sugar in real time and help patients with type ...

Editor’s Note: This article originally appeared on Abbott’s website. Abbott today announced that its Afinion™ HbA1c Dx assay is now available for use on the Afinion 2 Analyzer, as well as the Afinion ...

The gold standard long-term glucose monitoring test for patients with diabetes proved to be of limited value in dialysis patients, according to a new study. The gold standard long-term glucose ...

The devices have surged in popularity among people without diabetes, but a study suggests reality may not match the hype.View ...

March 4, 2011 — Recommendations for diagnosis of diabetes using hemoglobin A1c (HbA1c) level in adults may not be accurately extrapolated to adolescents, according to the results of a study using data ...

Early customers include GP offices and other community-based healthcare settings Latest figures, released as part of World Diabetes Day, reveal that 1 in 10 adults are now living with diabetes and ...

ABBOTT PARK, Ill., July 10, 2012 /PRNewswire/ -- More than 346 million people worldwide are living with diabetes, and the World Diabetes Foundation estimates that number will increase by nearly 27 ...

A common but often undiagnosed genetic condition may be causing delays in type 2 diabetes diagnoses and increasing the risk ...

WINSTON-SALEM, N.C. – May 31, 2011 – The gold standard long-term glucose monitoring test for patients with diabetes proved to be of limited value in dialysis patients, according to a new study at Wake ...

LONDON, Nov. 14, 2022 /PRNewswire/ -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced the continued commercial expansion of its HbA1c test, for ...